{"id":1969,"date":"2021-02-05T10:09:03","date_gmt":"2021-02-05T10:09:03","guid":{"rendered":"https:\/\/www.thervacb.eu\/startseite\/"},"modified":"2025-10-22T11:19:09","modified_gmt":"2025-10-22T10:19:09","slug":"startseite","status":"publish","type":"page","link":"https:\/\/www.thervacb.eu\/de\/","title":{"rendered":"Startseite"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8220;1&#8243; fullwidth=&#8220;on&#8220; _builder_version=&#8220;4.16&#8243; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_fullwidth_slider use_text_overlay=&#8220;on&#8220; text_overlay_color=&#8220;rgba(6,66,58,0.25)&#8220; _builder_version=&#8220;4.22.1&#8243; custom_padding=&#8220;83px||65px|||&#8220; auto=&#8220;on&#8220; auto_ignore_hover=&#8220;on&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_slide heading=&#8220;TherVacB&#8220; button_text=&#8220;Mehr erfahren&#8220; button_link=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjEyMSIsImVuYWJsZV9odG1sIjoib2ZmIn19@&#8220; use_bg_overlay=&#8220;off&#8220; use_text_overlay=&#8220;on&#8220; arrows_custom_color=&#8220;#2d788c&#8220; dot_nav_custom_color=&#8220;#2d788c&#8220; text_border_radius=&#8220;10px&#8220; _builder_version=&#8220;4.22.1&#8243; _dynamic_attributes=&#8220;button_link&#8220; header_font=&#8220;|700|||||||&#8220; header_text_align=&#8220;center&#8220; body_text_align=&#8220;center&#8220; background_enable_color=&#8220;off&#8220; use_background_color_gradient=&#8220;on&#8220; background_color_gradient_direction=&#8220;90deg&#8220; background_color_gradient_stops=&#8220;rgba(0,0,0,0) 0%|rgba(0,0,0,0) 100%&#8220; background_color_gradient_overlays_image=&#8220;on&#8220; background_color_gradient_start=&#8220;rgba(0,0,0,0)&#8220; background_color_gradient_end=&#8220;rgba(0,0,0,0)&#8220; background_image=&#8220;https:\/\/www.thervacb.eu\/wp-content\/uploads\/3d-objects-of-hepatitis-b-viruses-in-abstract-plasma.jpg&#8220; background_enable_image=&#8220;on&#8220; text_orientation=&#8220;center&#8220; header_text_shadow_style=&#8220;preset1&#8243; header_text_shadow_color=&#8220;#706f6f&#8220; body_text_shadow_style=&#8220;preset1&#8243; body_text_shadow_color=&#8220;#706f6f&#8220; text_shadow_style=&#8220;preset1&#8243; text_shadow_color=&#8220;#706f6f&#8220; global_colors_info=&#8220;{}&#8220; sticky_transition=&#8220;on&#8220;]<\/p>\n<p>Neues Konzept zur Bek\u00e4mpfung der chronischen Hepatitis B<\/p>\n<p>[\/et_pb_slide][et_pb_slide heading=&#8220;TherVacB&#8220; button_text=&#8220;Mehr erfahren&#8220; button_link=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjQ5ODgiLCJlbmFibGVfaHRtbCI6Im9mZiJ9fQ==@&#8220; use_bg_overlay=&#8220;off&#8220; use_text_overlay=&#8220;on&#8220; arrows_custom_color=&#8220;#2d788c&#8220; dot_nav_custom_color=&#8220;#2d788c&#8220; text_border_radius=&#8220;10px&#8220; _builder_version=&#8220;4.16&#8243; _dynamic_attributes=&#8220;button_link&#8220; header_font=&#8220;|700|||||||&#8220; header_text_align=&#8220;center&#8220; body_text_align=&#8220;center&#8220; background_enable_color=&#8220;off&#8220; use_background_color_gradient=&#8220;on&#8220; background_color_gradient_direction=&#8220;90deg&#8220; background_color_gradient_stops=&#8220;rgba(0,0,0,0) 0%|rgba(0,0,0,0) 100%&#8220; background_color_gradient_overlays_image=&#8220;on&#8220; background_color_gradient_start=&#8220;rgba(0,0,0,0)&#8220; background_color_gradient_end=&#8220;rgba(0,0,0,0)&#8220; background_image=&#8220;https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb-labor_copyright-kurt-bauer-photojournalist.jpg&#8220; background_enable_image=&#8220;on&#8220; text_orientation=&#8220;center&#8220; header_text_shadow_style=&#8220;preset1&#8243; header_text_shadow_color=&#8220;#706f6f&#8220; body_text_shadow_style=&#8220;preset1&#8243; body_text_shadow_color=&#8220;#706f6f&#8220; text_shadow_style=&#8220;preset1&#8243; text_shadow_color=&#8220;#706f6f&#8220; global_colors_info=&#8220;{}&#8220; sticky_transition=&#8220;on&#8220;]<\/p>\n<p>Neue Hoffnung f\u00fcr Hepatitis-B-Patienten<\/p>\n<p>[\/et_pb_slide][\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_row column_structure=&#8220;1_2,1_2&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_text module_id=&#8220;mainheadlinenormal&#8220; _builder_version=&#8220;4.25.0&#8243; header_font=&#8220;||||||||&#8220; header_font_size=&#8220;34px&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h1><strong>TherVacB &#8211; EIN THERAPEUTISCHER IMPFSTOFF GEGEN HEPATITIS B<\/strong><\/h1>\n<h2><strong>Europ\u00e4ische Kommission und TherVacB b\u00fcndeln ihre Kr\u00e4fte<\/strong><\/h2>\n<p>Die Rolle der viralen Hepatitis als Bedrohung der \u00f6ffentlichen Gesundheit wurde lange Zeit untersch\u00e4tzt. Erst k\u00fcrzlich haben die Vereinten Nationen in ihrer &#8222;2030 Agenda f\u00fcr nachhaltige Entwicklung&#8220; zu internationalen Ma\u00dfnahmen zur Bek\u00e4mpfung der viralen Hepatitis und zur Reduzierung der Krankheitslast aufgerufen. Die Haupttodesursache ist das Hepatitis-B-Virus (HBV), das Leberzirrhose und Leberkrebs verursacht. Weltweit sterben jedes Jahr mehr als 1 Million Menschen an den Folgen einer HBV-Infektion.<\/p>\n<p>Zur Vorbeugung einer HBV-Infektion steht ein prophylaktischer Impfstoff zur Verf\u00fcgung, aber mehr als 3% der Weltbev\u00f6lkerung (ca. 254 Millionen Menschen) sind chronisch infiziert und profitieren nicht mehr von diesem Impfstoff. F\u00fcr Menschen, die an chronischer Hepatitis B leiden, gibt es bis heute keine heilende Behandlungsm\u00f6glichkeit.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_cta button_url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjEyMSIsImVuYWJsZV9odG1sIjoib2ZmIn19@&#8220; button_text=&#8220;\u00dcber das Projekt&#8220; _builder_version=&#8220;4.25.0&#8243; _dynamic_attributes=&#8220;button_url&#8220; header_font=&#8220;|700|||||||&#8220; header_text_color=&#8220;#ffffff&#8220; use_background_color_gradient=&#8220;on&#8220; background_color_gradient_direction=&#8220;214deg&#8220; background_color_gradient_stops=&#8220;#2d788c 0%|#1c9080 100%&#8220; background_color_gradient_start=&#8220;#2d788c&#8220; background_color_gradient_end=&#8220;#1c9080&#8243; background_enable_image=&#8220;off&#8220; custom_button=&#8220;on&#8220; button_bg_color=&#8220;#5cbdd9&#8243; button_on_hover=&#8220;off&#8220; animation_style=&#8220;flip&#8220; border_radii=&#8220;on|10px|10px|10px|10px&#8220; box_shadow_style=&#8220;preset1&#8243; box_shadow_style_button=&#8220;preset1&#8243; global_colors_info=&#8220;{}&#8220; custom_css_promo_button__hover_enabled=&#8220;on|hover&#8220; custom_css_promo_button__hover=&#8220;background-color: rgba(92, 189, 217,0.85) !important;&#8220;]<\/p>\n<p>Die Europ\u00e4ische Kommission hat daher das vom Helmholtz Zentrum M\u00fcnchen geleitete Projekt TherVacB f\u00fcr eine siebenj\u00e4hrige F\u00f6rderung im Rahmen des Programms Horizont 2020 ausgew\u00e4hlt.<br \/>Ein Konsortium f\u00fchrender Virologen, Immunologen und \u00c4rzte, die auf die Behandlung von viraler Hepatitis spezialisiert sind, wird einen neu entwickelten therapeutischen Impfstoff, TherVacB, als Immuntherapie zur Heilung von HBV einsetzen. TherVacB wird in einer klinischen Studie evaluiert, die im Juni 2025 in Europa und in Afrika beginnt.  Die Integration eines Partnerstandortes in Tansania soll helfen, lokale Kapazit\u00e4ten f\u00fcr die Diagnose und Behandlung von Hepatitis B aufzubauen und ein wichtiges Ziel des Konsortiums unterst\u00fctzen &#8211; das Bewusstsein f\u00fcr Hepatitis B zu erh\u00f6hen.<\/p>\n<p>[\/et_pb_cta][et_pb_image src=&#8220;https:\/\/www.thervacb.eu\/wp-content\/uploads\/icon-virus-white.png&#8220; _builder_version=&#8220;4.16&#8243; transform_translate_linked=&#8220;off&#8220; positioning=&#8220;absolute&#8220; position_origin_a=&#8220;bottom_right&#8220; vertical_offset=&#8220;-20px&#8220; horizontal_offset=&#8220;-47px&#8220; z_index=&#8220;202&#8243; width_tablet=&#8220;100%&#8220; width_phone=&#8220;&#8220; width_last_edited=&#8220;on|tablet&#8220; animation_style=&#8220;slide&#8220; animation_duration=&#8220;2000ms&#8220; animation_intensity_slide=&#8220;0%&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; background_color=&#8220;#2d788c&#8220; background_enable_image=&#8220;off&#8220; parallax=&#8220;on&#8220; parallax_method=&#8220;off&#8220; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_row column_structure=&#8220;1_3,1_3,1_3&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;||||false|false&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.16&#8243; background_enable_image=&#8220;off&#8220; background_blend=&#8220;screen&#8220; custom_padding=&#8220;14px|14px|14px|14px|false|false&#8220; border_radii=&#8220;on|6px|6px|6px|6px&#8220; box_shadow_style=&#8220;preset1&#8243; box_shadow_blur=&#8220;8px&#8220; global_colors_info=&#8220;{}&#8220; transform_styles__hover_enabled=&#8220;on|hover&#8220; transform_scale__hover_enabled=&#8220;on|hover&#8220; transform_translate__hover_enabled=&#8220;on|desktop&#8220; transform_rotate__hover_enabled=&#8220;on|desktop&#8220; transform_skew__hover_enabled=&#8220;on|desktop&#8220; transform_origin__hover_enabled=&#8220;on|desktop&#8220; transform_scale__hover=&#8220;105%|105%&#8220;][et_pb_blurb title=&#8220;\u00dcber TherVacB&#8220; use_icon=&#8220;on&#8220; icon_color=&#8220;#ffffff&#8220; _builder_version=&#8220;4.16&#8243; header_font=&#8220;|700|||||||&#8220; header_text_align=&#8220;center&#8220; header_text_color=&#8220;#ffffff&#8220; header_font_size=&#8220;24px&#8220; body_text_align=&#8220;center&#8220; body_text_color=&#8220;#ffffff&#8220; text_orientation=&#8220;center&#8220; custom_padding=&#8220;14px|14px|14px|14px|false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_blurb][et_pb_image src=&#8220;https:\/\/www.thervacb.eu\/wp-content\/uploads\/istock-1173676500-c.jpg&#8220; title_text=&#8220;iStock-1173676500-c&#8220; align=&#8220;center&#8220; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;14px|14px|14px|14px|false|false&#8220; border_radii=&#8220;on|6px|6px|6px|6px&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][et_pb_button button_url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjEyMSIsImVuYWJsZV9odG1sIjoib2ZmIn19@&#8220; button_text=&#8220;Mehr erfahren&#8220; button_alignment=&#8220;center&#8220; _builder_version=&#8220;4.16&#8243; _dynamic_attributes=&#8220;button_url&#8220; custom_padding=&#8220;14px||14px|14px|false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;14px|14px|14px|14px|false|false&#8220; border_radii=&#8220;on|6px|6px|6px|6px&#8220; box_shadow_style=&#8220;preset1&#8243; box_shadow_blur=&#8220;8px&#8220; global_colors_info=&#8220;{}&#8220; transform_styles__hover_enabled=&#8220;on|hover&#8220; transform_scale__hover_enabled=&#8220;on|hover&#8220; transform_translate__hover_enabled=&#8220;on|hover&#8220; transform_rotate__hover_enabled=&#8220;on|desktop&#8220; transform_skew__hover_enabled=&#8220;on|desktop&#8220; transform_origin__hover_enabled=&#8220;on|desktop&#8220; transform_scale__hover=&#8220;105%|105%&#8220;][et_pb_blurb title=&#8220;F\u00fcr Patienten&#8220; use_icon=&#8220;on&#8220; icon_color=&#8220;#ffffff&#8220; _builder_version=&#8220;4.16&#8243; header_font=&#8220;|700|||||||&#8220; header_text_align=&#8220;center&#8220; header_text_color=&#8220;#ffffff&#8220; header_font_size=&#8220;24px&#8220; body_text_align=&#8220;center&#8220; body_text_color=&#8220;#ffffff&#8220; text_orientation=&#8220;center&#8220; custom_padding=&#8220;14px|14px|14px|14px|false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_blurb][et_pb_image src=&#8220;https:\/\/www.thervacb.eu\/wp-content\/uploads\/hepatitis.jpg&#8220; title_text=&#8220;iStock-1197389162-c&#8220; align=&#8220;center&#8220; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;14px|14px|14px|14px|false|false&#8220; border_radii=&#8220;on|6px|6px|6px|6px&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][et_pb_button button_url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjQ5ODgiLCJlbmFibGVfaHRtbCI6Im9mZiJ9fQ==@&#8220; button_text=&#8220;Mehr erfahren&#8220; button_alignment=&#8220;center&#8220; _builder_version=&#8220;4.16&#8243; _dynamic_attributes=&#8220;button_url&#8220; custom_padding=&#8220;14px||14px|14px|false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;14px|14px|14px|14px|false|false&#8220; border_radii=&#8220;on|6px|6px|6px|6px&#8220; box_shadow_style=&#8220;preset1&#8243; box_shadow_blur=&#8220;8px&#8220; global_colors_info=&#8220;{}&#8220; transform_styles__hover_enabled=&#8220;on|hover&#8220; transform_scale__hover_enabled=&#8220;on|hover&#8220; transform_translate__hover_enabled=&#8220;on|hover&#8220; transform_rotate__hover_enabled=&#8220;on|desktop&#8220; transform_skew__hover_enabled=&#8220;on|desktop&#8220; transform_origin__hover_enabled=&#8220;on|desktop&#8220; transform_scale__hover=&#8220;105%|105%&#8220;][et_pb_blurb title=&#8220;TherVacB-Team&#8220; use_icon=&#8220;on&#8220; icon_color=&#8220;#ffffff&#8220; _builder_version=&#8220;4.16&#8243; header_font=&#8220;|700|||||||&#8220; header_text_align=&#8220;center&#8220; header_text_color=&#8220;#ffffff&#8220; header_font_size=&#8220;24px&#8220; body_text_align=&#8220;center&#8220; body_text_color=&#8220;#ffffff&#8220; text_orientation=&#8220;center&#8220; custom_padding=&#8220;14px|14px|14px|14px|false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_blurb][et_pb_image src=&#8220;https:\/\/www.thervacb.eu\/wp-content\/uploads\/the-thervacb-consortium-consists-of-sixteen-partners-from-five-different-european-countries-and-one-from-africa-tansania.jpg&#8220; title_text=&#8220;iStock-912134878-c&#8220; align=&#8220;center&#8220; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;14px|14px|14px|14px|false|false&#8220; border_radii=&#8220;on|6px|6px|6px|6px&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][et_pb_button button_url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjEyMiIsImVuYWJsZV9odG1sIjoib2ZmIn19@&#8220; button_text=&#8220;Mehr erfahren&#8220; button_alignment=&#8220;center&#8220; _builder_version=&#8220;4.16&#8243; _dynamic_attributes=&#8220;button_url&#8220; custom_padding=&#8220;14px||14px|14px|false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_row module_id=&#8220;zitatslide&#8220; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;40px|||||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_slider show_pagination=&#8220;off&#8220; arrows_custom_color=&#8220;#1c9080&#8243; dot_nav_custom_color=&#8220;#1c9080&#8243; _builder_version=&#8220;4.25.0&#8243; header_font=&#8220;||on||||||&#8220; background_color=&#8220;#ffffff&#8220; min_height=&#8220;200px&#8220; height=&#8220;200px&#8220; max_height=&#8220;200px&#8220; custom_padding=&#8220;4px||3px|||&#8220; animation_style=&#8220;flip&#8220; auto=&#8220;on&#8220; auto_ignore_hover=&#8220;on&#8220; header_font_size_tablet=&#8220;24px&#8220; header_font_size_phone=&#8220;18px&#8220; header_font_size_last_edited=&#8220;on|phone&#8220; border_radii=&#8220;on|10px|10px|10px|10px&#8220; border_width_all=&#8220;1px&#8220; border_color_all=&#8220;#bdbdbd&#8220; border_color_all_image=&#8220;#5cbdd9&#8243; box_shadow_style=&#8220;preset1&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_slide heading=&#8220;\u201cIch freue mich sehr, dass wir f\u00fcr die klinischen Studien von TherVacB mit einem Konsortium aus Europas f\u00fchrenden Virologen, Immunologen und Hepatologen zusammenarbeiten k\u00f6nnen. Dies wird f\u00fcr die Patienten, die chronisch mit dem Hepatitis-B-Virus infiziert sind, von gro\u00dfem Nutzen sein.%22 &#8220; image=&#8220;https:\/\/www.thervacb.eu\/wp-content\/uploads\/hmgu-ulrike-protzer.jpg&#8220; use_bg_overlay=&#8220;off&#8220; image_alt=&#8220;Inken Schm\u00fctz_400x400&#8243; _builder_version=&#8220;4.25.0&#8243; header_font=&#8220;|700|on||||||&#8220; header_text_color=&#8220;#1c9080&#8243; header_font_size=&#8220;18px&#8220; body_text_color=&#8220;#706f6f&#8220; body_line_height=&#8220;1.4em&#8220; background_enable_color=&#8220;off&#8220; header_font_size_tablet=&#8220;16px&#8220; header_font_size_phone=&#8220;16px&#8220; header_font_size_last_edited=&#8220;on|tablet&#8220; body_font_size_tablet=&#8220;14px&#8220; body_font_size_phone=&#8220;&#8220; body_font_size_last_edited=&#8220;on|phone&#8220; custom_css_main_element=&#8220;border-radius:10px;||||&#8220; global_colors_info=&#8220;{}&#8220; sticky_transition=&#8220;on&#8220;]<\/p>\n<p><span style=\"color: #2d788c; font-weight: bold;\">Ulrike Protzer<\/span><br \/>Project Coordinator<br \/>Helmholtz Zentrum M\u00fcnchen<\/p>\n<p>[\/et_pb_slide][\/et_pb_slider][et_pb_image src=&#8220;https:\/\/www.thervacb.eu\/wp-content\/uploads\/icon-virus-color.png&#8220; _builder_version=&#8220;4.16&#8243; positioning=&#8220;absolute&#8220; vertical_offset=&#8220;-36px&#8220; horizontal_offset=&#8220;-49px&#8220; z_index=&#8220;436&#8243; width=&#8220;100%&#8220; animation_style=&#8220;slide&#8220; animation_direction=&#8220;left&#8220; animation_duration=&#8220;2000ms&#8220; animation_intensity_slide=&#8220;0%&#8220; scroll_fade_enable=&#8220;on&#8220; scroll_fade=&#8220;0|70|70|100|0|100|100&#8243; scroll_scaling_enable=&#8220;on&#8220; scroll_scaling=&#8220;0|50|50|100|70|105%|100&#8243; motion_trigger_start=&#8220;top&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; background_enable_color=&#8220;off&#8220; background_color_gradient_direction=&#8220;90deg&#8220; background_image=&#8220;https:\/\/www.thervacb.eu\/wp-content\/uploads\/istock-958097178.jpg&#8220; parallax=&#8220;on&#8220; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_row column_structure=&#8220;1_3,1_3,1_3&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_number_counter title=&#8220;Partner&#8220; number=&#8220;17&#8243; percent_sign=&#8220;off&#8220; _builder_version=&#8220;4.25.0&#8243; title_font=&#8220;|700|||||||&#8220; title_text_color=&#8220;#ffffff&#8220; title_font_size=&#8220;36px&#8220; number_font=&#8220;|700|||||||&#8220; number_text_color=&#8220;#ffffff&#8220; background_enable_color=&#8220;off&#8220; background_enable_image=&#8220;off&#8220; custom_margin=&#8220;||||false|false&#8220; custom_padding=&#8220;||||false|false&#8220; animation_style=&#8220;slide&#8220; animation_direction=&#8220;bottom&#8220; animation_intensity_slide=&#8220;0%&#8220; title_text_shadow_style=&#8220;preset1&#8243; number_text_shadow_style=&#8220;preset1&#8243; text_shadow_style=&#8220;preset1&#8243; text_shadow_color=&#8220;rgba(0,0,0,0)&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_number_counter title=&#8220;L\u00e4nder&#8220; number=&#8220;5&#8243; percent_sign=&#8220;off&#8220; _builder_version=&#8220;4.25.0&#8243; title_font=&#8220;|700|||||||&#8220; title_text_color=&#8220;#ffffff&#8220; title_font_size=&#8220;36px&#8220; number_font=&#8220;|700|||||||&#8220; number_text_color=&#8220;#ffffff&#8220; custom_margin=&#8220;||||false|false&#8220; animation_style=&#8220;slide&#8220; animation_direction=&#8220;bottom&#8220; animation_delay=&#8220;300ms&#8220; animation_intensity_slide=&#8220;0%&#8220; title_text_shadow_style=&#8220;preset1&#8243; number_text_shadow_style=&#8220;preset1&#8243; text_shadow_style=&#8220;preset1&#8243; text_shadow_color=&#8220;rgba(0,0,0,0)&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_number_counter title=&#8220;Monate Projektdauer&#8220; number=&#8220;84&#8243; percent_sign=&#8220;off&#8220; _builder_version=&#8220;4.25.0&#8243; title_font=&#8220;|700|||||||&#8220; title_text_color=&#8220;#ffffff&#8220; title_font_size=&#8220;36px&#8220; number_font=&#8220;|700|||||||&#8220; number_text_color=&#8220;#ffffff&#8220; custom_margin=&#8220;||||false|false&#8220; animation_style=&#8220;slide&#8220; animation_direction=&#8220;bottom&#8220; animation_delay=&#8220;600ms&#8220; animation_intensity_slide=&#8220;0%&#8220; title_text_shadow_style=&#8220;preset1&#8243; number_text_shadow_style=&#8220;preset1&#8243; text_shadow_style=&#8220;preset1&#8243; text_shadow_color=&#8220;rgba(0,0,0,0)&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_blog fullwidth=&#8220;off&#8220; posts_number=&#8220;3&#8243; include_categories=&#8220;16,64&#8243; show_author=&#8220;off&#8220; show_categories=&#8220;off&#8220; show_pagination=&#8220;off&#8220; _builder_version=&#8220;4.25.0&#8243; body_text_color=&#8220;#1d1d1b&#8220; body_line_height=&#8220;1.2em&#8220; meta_font_size=&#8220;12px&#8220; animation_style=&#8220;flip&#8220; border_radii=&#8220;on|6px|6px|6px|6px&#8220; box_shadow_style=&#8220;preset1&#8243; box_shadow_vertical=&#8220;1px&#8220; box_shadow_blur=&#8220;6px&#8220; box_shadow_color=&#8220;#bdbdbd&#8220; global_colors_info=&#8220;{}&#8220; transform_styles__hover_enabled=&#8220;on|hover&#8220; transform_scale__hover_enabled=&#8220;on|hover&#8220; transform_translate__hover_enabled=&#8220;on|desktop&#8220; transform_rotate__hover_enabled=&#8220;on|desktop&#8220; transform_skew__hover_enabled=&#8220;on|desktop&#8220; transform_origin__hover_enabled=&#8220;on|desktop&#8220;][\/et_pb_blog][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; background_color=&#8220;#2d788c&#8220; background_color_gradient_direction=&#8220;90deg&#8220; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_row column_structure=&#8220;2_5,3_5&#8243; use_custom_gutter=&#8220;on&#8220; gutter_width=&#8220;2&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;2_5&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.16&#8243; text_text_color=&#8220;#ffffff&#8220; header_text_color=&#8220;#ffffff&#8220; header_2_font=&#8220;|||on|||||&#8220; header_2_text_color=&#8220;#FFFFFF&#8220; header_2_font_size=&#8220;36px&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2 class=\"title style-scope ytd-video-primary-info-renderer\">Animation movie<\/h2>\n<p class=\"title style-scope ytd-video-primary-info-renderer\">Enjoy our animation movie to understand the mission and approach of the TherVacB project!<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;3_5&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_video src=&#8220;https:\/\/youtu.be\/pjrXqF_yXXY&#8220; disabled_on=&#8220;on|on|on&#8220; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;0px|||||&#8220; disabled=&#8220;on&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_video][et_pb_code _builder_version=&#8220;4.21.0&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;]<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube-nocookie.com\/embed\/pjrXqF_yXXY\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;0px|||||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_button button_url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjEzMDAiLCJlbmFibGVfaHRtbCI6Im9mZiJ9fQ==@&#8220; button_text=&#8220;Mehr Videos sehen&#8220; button_alignment=&#8220;right&#8220; _builder_version=&#8220;4.16&#8243; _dynamic_attributes=&#8220;button_url&#8220; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_text module_id=&#8220;mainheadlinenormal&#8220; _builder_version=&#8220;4.22.1&#8243; header_font=&#8220;||||||||&#8220; header_font_size=&#8220;34px&#8220; header_2_font=&#8220;|||on|||||&#8220; header_2_font_size=&#8220;36px&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2><strong>TherVacB Ver\u00f6ffentlichungen<\/strong><\/h2>\n<h3><strong>Hier finden Sie wissenschaftliche Ver\u00f6ffentlichungen und technische Artikel der TherVacB-Projektpartner.<\/strong><\/h3>\n<p><strong>Lesen Sie mehr \u00fcber chronische Hepatitis B, das Virus, Screening und Tests f\u00fcr Hepatitis C und B, therapeutische Impfungen und die Forschung zur Heilung.<\/strong><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;5px|||||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_button button_url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjgzODQiLCJlbmFibGVfaHRtbCI6Im9mZiJ9fQ==@&#8220; button_text=&#8220;Zu den Ver\u00f6ffentlichungen&#8220; button_alignment=&#8220;right&#8220; _builder_version=&#8220;4.16&#8243; _dynamic_attributes=&#8220;button_url&#8220; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; background_color=&#8220;#2d788c&#8220; background_color_gradient_direction=&#8220;90deg&#8220; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.21.0&#8243; text_text_color=&#8220;#ffffff&#8220; header_text_color=&#8220;#ffffff&#8220; header_2_font=&#8220;|||on|||||&#8220; header_2_text_color=&#8220;#FFFFFF&#8220; header_2_font_size=&#8220;36px&#8220; custom_margin=&#8220;||0px||false|false&#8220; custom_padding=&#8220;||0px||false|false&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2 class=\"title style-scope ytd-video-primary-info-renderer\">Alles, was Sie wissen m\u00fcssen, um die Forschung zur Heilung von Hepatitis B zu verstehen &#8211; The HBV Cure FAQs<\/h2>\n<p class=\"title style-scope ytd-video-primary-info-renderer\">Sehen Sie sich die wachsende Sammlung von Kurzvideos an, in denen Menschen, die mit Hepatitis B (HBV) leben, wichtige Fragen zur Heilungsforschung beantworten. Sehen Sie sich die wachsende Sammlung von Kurzvideos an, in denen Menschen, die mit Hepatitis B (HBV) leben, wichtige Fragen zur Heilungsforschung beantworten. Die Sammlung ist ein Produkt eines internationalen Konsortiums von Organisationen, Fachinstitutionen und Forschungsprojekten, die sich mit Hepatitis B besch\u00e4ftigen. Aktiv beteiligt sind ICE-HBV, Hepatitis B Foundation, World Hepatitis Alliance, HepBCommunity.org, Australian Centre for Hepatitis Virology, IP-cure-B, das Canadian HBV Network und TherVacB. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8220;1_2,1_2&#8243; use_custom_gutter=&#8220;on&#8220; gutter_width=&#8220;2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_code _builder_version=&#8220;4.21.0&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;]<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube-nocookie.com\/embed\/55pdarnC1Xk\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\"><\/iframe>[\/et_pb_code][\/et_pb_column][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_code _builder_version=&#8220;4.21.0&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;]<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube-nocookie.com\/embed\/yQC2vgTpdZQ\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\"><\/iframe>[\/et_pb_code][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;0px|||||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_button button_url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6Ijg2NTgiLCJlbmFibGVfaHRtbCI6Im9mZiJ9fQ==@&#8220; button_text=&#8220;Weitere Fragen? Find all HBV Cure FAQ videos here&#8220; button_alignment=&#8220;right&#8220; _builder_version=&#8220;4.16&#8243; _dynamic_attributes=&#8220;button_url&#8220; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; da_disable_devices=&#8220;off|off|off&#8220; global_colors_info=&#8220;{}&#8220; da_is_popup=&#8220;off&#8220; da_exit_intent=&#8220;off&#8220; da_has_close=&#8220;on&#8220; da_alt_close=&#8220;off&#8220; da_dark_close=&#8220;off&#8220; da_not_modal=&#8220;on&#8220; da_is_singular=&#8220;off&#8220; da_with_loader=&#8220;off&#8220; da_has_shadow=&#8220;on&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n\n<!-- Custom Twitter Feeds by Smash Balloon -->\n<div id=\"ctf\"  class=\"ctf ctf-type-usertimeline  ctf-masonry masonry-2-desktop ctf-styles ctf-feed-4 ctf-masonry ctf-regular-style ctf-rebranded-x\"  data-ctfshortcode=\"{&quot;feed&quot;:&quot;4&quot;}\"  data-ctfdisablelinks=\"false\" data-ctflinktextcolor=\"#\" data-ctfmaxmedia=\"4\" data-ctfimagecols=\"auto\" data-ctf-cols=\"2\" data-ctf-tabletcols=\"2\" data-ctf-mobilecols=\"1\" data-header-size=\"small\" data-feedid=\"4\" data-postid=\"1969\"  data-feed=\"4\" data-ctf-flags=\"gdpr\" data-ctfneeded=\"-98\">\n\t\n    \n<div class=\"ctf-header ctf-no-bio\" style=\"##\" >\n    <a href=\"https:\/\/twitter.com\/TherVacB_EU\/\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" title=\"@TherVacB_EU\" class=\"ctf-header-link\">\n        <div class=\"ctf-header-text\">\n            <p class=\"ctf-header-user\">\n                <span class=\"ctf-header-name\">TherVacB Project<\/span>\n                <span class=\"ctf-verified\"><\/span>\n                <span class=\"ctf-header-follow\">Folgen<\/span>\n                <span class=\"ctf-header-counts\">\n                    <span class=\"ctf-header-tweets-count\" title=\"736 Tweets\"><svg class=\"svg-inline--fa fa-twitter fa-w-16\" aria-hidden=\"true\" aria-label=\"twitter logo\" data-fa-processed=\"\" data-prefix=\"fab\" data-icon=\"twitter\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path fill=\"currentColor\" d=\"M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z\"><\/path><\/svg>736<\/span>\n                    <span class=\"ctf-header-followers\"  title=\"1,112 Followers\"><svg class=\"svg-inline--fa fa-user fa-w-16\" aria-hidden=\"true\" aria-label=\"followers\" data-fa-processed=\"\" data-prefix=\"fa\" data-icon=\"user\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path fill=\"currentColor\" d=\"M96 160C96 71.634 167.635 0 256 0s160 71.634 160 160-71.635 160-160 160S96 248.366 96 160zm304 192h-28.556c-71.006 42.713-159.912 42.695-230.888 0H112C50.144 352 0 402.144 0 464v24c0 13.255 10.745 24 24 24h464c13.255 0 24-10.745 24-24v-24c0-61.856-50.144-112-112-112z\"><\/path><\/svg>1,112<\/span>\n                <\/span>\n            <\/p>\n                            <p class=\"ctf-header-bio\"  >\n                    EU-funded #H2020 project developing a therapeutic vaccine to cure #HepatitisB.\n\ud83e\udd8bhttps:\/\/t.co\/THT7rFlHR8 | \ud83d\udcfayt\/@TherVacB | \ud83d\udd17Linkedin\/company\/thervacb-project                <\/p>\n                    <\/div>\n        <div class=\"ctf-header-img\">\n            <div class=\"ctf-header-img-hover ctf-rebranded \">\n                <svg width=\"30\" height=\"30\" viewBox=\"0 0 30 30\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M21.1161 6.27344H24.2289L17.4284 14.0459L25.4286 24.6225H19.1645L14.2583 18.2079L8.6444 24.6225H5.52976L12.8035 16.309L5.12891 6.27344H11.552L15.9868 12.1367L21.1161 6.27344ZM20.0236 22.7594H21.7484L10.6148 8.03871H8.7639L20.0236 22.7594Z\" fill=\"black\"\/>\n\t\t\t<\/svg>            <\/div>\n            <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.thervacb.eu\/wp-content\/uploads\/sb-twitter-feed-images\/TherVacB_EU.jpg\" alt=\"TherVacB_EU\" width=\"48\" height=\"48\">\n        <\/div>\n    <\/a>\n<\/div>\n\n    <div class=\"ctf-tweet-items\">\n    \n<div class=\"ctf-item ctf-author-thervacb_eu ctf-new ctf-transition ctf-with-logo ctf-retweet\" id=\"ctf_2085275144608440456\">\n\n    <div class=\"ctf-context\" >\n    <a href=\"https:\/\/twitter.com\/intent\/user?screen_name=TherVacB_EU\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-retweet-icon\"><svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"retweet\" role=\"img\"><path fill=\"currentColor\" d=\"M23.77 15.67c-.292-.293-.767-.293-1.06 0l-2.22 2.22V7.65c0-2.068-1.683-3.75-3.75-3.75h-5.85c-.414 0-.75.336-.75.75s.336.75.75.75h5.85c1.24 0 2.25 1.01 2.25 2.25v10.24l-2.22-2.22c-.293-.293-.768-.293-1.06 0s-.294.768 0 1.06l3.5 3.5c.145.147.337.22.53.22s.383-.072.53-.22l3.5-3.5c.294-.292.294-.767 0-1.06zm-10.66 3.28H7.26c-1.24 0-2.25-1.01-2.25-2.25V6.46l2.22 2.22c.148.147.34.22.532.22s.384-.073.53-.22c.293-.293.293-.768 0-1.06l-3.5-3.5c-.293-.294-.768-.294-1.06 0l-3.5 3.5c-.294.292-.294.767 0 1.06s.767.293 1.06 0l2.22-2.22V16.7c0 2.068 1.683 3.75 3.75 3.75h5.85c.414 0 .75-.336.75-.75s-.337-.75-.75-.75z\"><\/path><\/svg><span class=\"ctf-screenreader\">Retweet auf Twitter<\/span><\/a>\n    <a href=\"https:\/\/twitter.com\/thervacb_eu\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-retweet-text\">TherVacB Project Retweetet<\/a>\n<\/div>\n\n<div class=\"ctf-author-box\">\n    <div class=\"ctf-author-box-link\">\n                                    <a href=\"https:\/\/twitter.com\/hepbfoundation\" class=\"ctf-author-avatar\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >\n                    <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/img\/placeholder.png\" alt=\"HepBFoundation avatar\" data-avatar=\"https:\/\/pbs.twimg.com\/profile_images\/2074944016383094784\/zyZCH-Es_normal.jpg\" width=\"48\" height=\"48\">;\n                <\/a>\n            \n                            <a href=\"https:\/\/twitter.com\/hepbfoundation\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-author-name\" >Hepatitis B Foundation<\/a>\n                                <a href=\"https:\/\/twitter.com\/hepbfoundation\" class=\"ctf-author-screenname\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >@HepBFoundation<\/a>\n                    \n        \t\t                    <span class=\"ctf-screename-sep\" >&middot;<\/span>\n\t                    <div class=\"ctf-tweet-meta\" >\n              <a href=\"https:\/\/twitter.com\/hepbfoundation\/status\/2084640936907141296\" class=\"ctf-tweet-date\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >4 Aug. <span class=\"ctf-screenreader\"> 2084640936907141296<\/span><\/a>\n            <\/div>\n            <\/div>\n            <div class=\"ctf-corner-logo\" >\n            <svg width=\"30\" height=\"30\" viewBox=\"0 0 30 30\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M21.1161 6.27344H24.2289L17.4284 14.0459L25.4286 24.6225H19.1645L14.2583 18.2079L8.6444 24.6225H5.52976L12.8035 16.309L5.12891 6.27344H11.552L15.9868 12.1367L21.1161 6.27344ZM20.0236 22.7594H21.7484L10.6148 8.03871H8.7639L20.0236 22.7594Z\" fill=\"black\"\/>\n\t\t\t<\/svg>        <\/div>\n    <\/div>\n\n        <div class=\"ctf-tweet-content ctf-disable-lightbox\">\n        \t\t\t\t<p class=\"ctf-tweet-text\">#BLOG: New hepatitis delta drug, Hepcludex, now approved in the U.S.<br \/>\n<br \/>\n\ud83e\uddec Big news in liver health: the FDA has approved #Hepcludex (bulevirtide) for hepatitis delta, the most severe form of viral hepatitis. <br \/>\n<br \/>\nRead the full story on our blog \ud83d\udc47<br \/>\nhttps:\/\/www.hepb.org\/blog\/<br \/>\n<br \/>\n#FDA <\/p>\n\t\t\t\t\t\t\n        \n<div class=\"ctf-tweet-media\"  data-available-images=\"[{&quot;150&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO4h4qlXkAE2Pl3.jpg:thumb&quot;,&quot;680&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO4h4qlXkAE2Pl3.jpg:small&quot;,&quot;940&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO4h4qlXkAE2Pl3.jpg:large&quot;}]\" >\n    \n                            <a href=\"https:\/\/twitter.com\/HepBFoundation\/status\/2084640936907141296\" class=\"ctf-media-link\" data-bg-image=\"https:\/\/pbs.twimg.com\/media\/HO4h4qlXkAE2Pl3.jpg\"  target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n                        <svg aria-label=\"play button\" style=\"color: rgba(255,255,255,1)\" class=\"svg-inline--fa fa-play fa-w-14 ctf_playbtn\" aria-hidden=\"true\" data-fa-processed=\"\" data-prefix=\"fa\" data-icon=\"play\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path fill=\"currentColor\" d=\"M424.4 214.7L72.4 6.6C43.8-10.3 0 6.1 0 47.9V464c0 37.5 40.7 60.1 72.4 41.3l352-208c31.4-18.5 31.5-64.1 0-82.6z\"><\/path><\/svg>                \n                                    <img decoding=\"async\" src=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/img\/placeholder.png\" alt=\"Bild f\u00fcr den Anfang des Tweets: #BLOG: New hepatitis delta drug,\"  data-ctfsizes=\"150,680,940,940\" data-full-image=\"https:\/\/pbs.twimg.com\/media\/HO4h4qlXkAE2Pl3.jpg\">\n                \n                <span class=\"ctf-screenreader\">Twitter Feed Bild.<\/span>                        <\/a>\n                        \n    <\/div>\n\n\t    \n        \n    <\/div>\n    \n\t\n    <div class=\"ctf-tweet-actions\" >\n            <a href=\"https:\/\/twitter.com\/intent\/tweet?in_reply_to=2084640936907141296&#038;related=hepbfoundation\" class=\"ctf-reply\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-label=\"reply\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><g><path fill=\"currentColor\" d=\"M14.046 2.242l-4.148-.01h-.002c-4.374 0-7.8 3.427-7.8 7.802 0 4.098 3.186 7.206 7.465 7.37v3.828c0 .108.044.286.12.403.142.225.384.347.632.347.138 0 .277-.038.402-.118.264-.168 6.473-4.14 8.088-5.506 1.902-1.61 3.04-3.97 3.043-6.312v-.017c-.006-4.367-3.43-7.787-7.8-7.788zm3.787 12.972c-1.134.96-4.862 3.405-6.772 4.643V16.67c0-.414-.335-.75-.75-.75h-.396c-3.66 0-6.318-2.476-6.318-5.886 0-3.534 2.768-6.302 6.3-6.302l4.147.01h.002c3.532 0 6.3 2.766 6.302 6.296-.003 1.91-.942 3.844-2.514 5.176z\"><\/path><\/g><\/svg>            <span class=\"ctf-screenreader\">Auf Twitter antworten 2084640936907141296<\/span>\n        <\/a>\n\n        <a href=\"https:\/\/twitter.com\/intent\/retweet?tweet_id=2084640936907141296&#038;related=hepbfoundation\" class=\"ctf-retweet\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"retweet\" role=\"img\"><path fill=\"currentColor\" d=\"M23.77 15.67c-.292-.293-.767-.293-1.06 0l-2.22 2.22V7.65c0-2.068-1.683-3.75-3.75-3.75h-5.85c-.414 0-.75.336-.75.75s.336.75.75.75h5.85c1.24 0 2.25 1.01 2.25 2.25v10.24l-2.22-2.22c-.293-.293-.768-.293-1.06 0s-.294.768 0 1.06l3.5 3.5c.145.147.337.22.53.22s.383-.072.53-.22l3.5-3.5c.294-.292.294-.767 0-1.06zm-10.66 3.28H7.26c-1.24 0-2.25-1.01-2.25-2.25V6.46l2.22 2.22c.148.147.34.22.532.22s.384-.073.53-.22c.293-.293.293-.768 0-1.06l-3.5-3.5c-.293-.294-.768-.294-1.06 0l-3.5 3.5c-.294.292-.294.767 0 1.06s.767.293 1.06 0l2.22-2.22V16.7c0 2.068 1.683 3.75 3.75 3.75h5.85c.414 0 .75-.336.75-.75s-.337-.75-.75-.75z\"><\/path><\/svg>            <span class=\"ctf-screenreader\">Retweet auf Twitter 2084640936907141296<\/span>\n            <span class=\"ctf-action-count ctf-retweet-count\">3<\/span>\n        <\/a>\n\n        <a href=\"https:\/\/twitter.com\/intent\/like?tweet_id=2084640936907141296&#038;related=hepbfoundation\" class=\"ctf-like\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"like\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><g><path fill=\"currentColor\" d=\"M12 21.638h-.014C9.403 21.59 1.95 14.856 1.95 8.478c0-3.064 2.525-5.754 5.403-5.754 2.29 0 3.83 1.58 4.646 2.73.814-1.148 2.354-2.73 4.645-2.73 2.88 0 5.404 2.69 5.404 5.755 0 6.376-7.454 13.11-10.037 13.157H12zM7.354 4.225c-2.08 0-3.903 1.988-3.903 4.255 0 5.74 7.034 11.596 8.55 11.658 1.518-.062 8.55-5.917 8.55-11.658 0-2.267-1.823-4.255-3.903-4.255-2.528 0-3.94 2.936-3.952 2.965-.23.562-1.156.562-1.387 0-.014-.03-1.425-2.965-3.954-2.965z\"><\/path><\/g><\/svg>            <span class=\"ctf-screenreader\">Auf Twitter liken 2084640936907141296<\/span>\n            <span class=\"ctf-action-count ctf-favorite-count\">2<\/span>\n        <\/a>\n\n                    <a href=\"https:\/\/twitter.com\/hepbfoundation\/status\/2084640936907141296\" class=\"ctf-twitterlink\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >\n                <span >Twitter<\/span>\n                <span class=\"ctf-screenreader\">2084640936907141296<\/span>\n            <\/a>\n            \n\t<\/div>\n\n\t<\/div>\n\n\n<div class=\"ctf-item ctf-author-thervacb_eu ctf-new ctf-transition ctf-with-logo ctf-retweet\" id=\"ctf_2085274868308721706\">\n\n    <div class=\"ctf-context\" >\n    <a href=\"https:\/\/twitter.com\/intent\/user?screen_name=TherVacB_EU\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-retweet-icon\"><svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"retweet\" role=\"img\"><path fill=\"currentColor\" d=\"M23.77 15.67c-.292-.293-.767-.293-1.06 0l-2.22 2.22V7.65c0-2.068-1.683-3.75-3.75-3.75h-5.85c-.414 0-.75.336-.75.75s.336.75.75.75h5.85c1.24 0 2.25 1.01 2.25 2.25v10.24l-2.22-2.22c-.293-.293-.768-.293-1.06 0s-.294.768 0 1.06l3.5 3.5c.145.147.337.22.53.22s.383-.072.53-.22l3.5-3.5c.294-.292.294-.767 0-1.06zm-10.66 3.28H7.26c-1.24 0-2.25-1.01-2.25-2.25V6.46l2.22 2.22c.148.147.34.22.532.22s.384-.073.53-.22c.293-.293.293-.768 0-1.06l-3.5-3.5c-.293-.294-.768-.294-1.06 0l-3.5 3.5c-.294.292-.294.767 0 1.06s.767.293 1.06 0l2.22-2.22V16.7c0 2.068 1.683 3.75 3.75 3.75h5.85c.414 0 .75-.336.75-.75s-.337-.75-.75-.75z\"><\/path><\/svg><span class=\"ctf-screenreader\">Retweet auf Twitter<\/span><\/a>\n    <a href=\"https:\/\/twitter.com\/thervacb_eu\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-retweet-text\">TherVacB Project Retweetet<\/a>\n<\/div>\n\n<div class=\"ctf-author-box\">\n    <div class=\"ctf-author-box-link\">\n                                    <a href=\"https:\/\/twitter.com\/gavi\" class=\"ctf-author-avatar\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >\n                    <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/img\/placeholder.png\" alt=\"gavi avatar\" data-avatar=\"https:\/\/pbs.twimg.com\/profile_images\/1543928698373656576\/A3uVPpS3_normal.jpg\" width=\"48\" height=\"48\">;\n                <\/a>\n            \n                            <a href=\"https:\/\/twitter.com\/gavi\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-author-name\" >Gavi, the Vaccine Alliance<\/a>\n                                    <span class=\"ctf-verified\" ><svg class=\"svg-inline--fa fa-check-circle fa-w-16\" aria-hidden=\"true\" aria-label=\"verified\" data-fa-processed=\"\" data-prefix=\"fa\" data-icon=\"check-circle\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path fill=\"currentColor\" d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg><\/span>\n                                <a href=\"https:\/\/twitter.com\/gavi\" class=\"ctf-author-screenname\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >@gavi<\/a>\n                    \n        \t\t                    <span class=\"ctf-screename-sep\" >&middot;<\/span>\n\t                    <div class=\"ctf-tweet-meta\" >\n              <a href=\"https:\/\/twitter.com\/gavi\/status\/2085018381833347219\" class=\"ctf-tweet-date\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >5 Aug. <span class=\"ctf-screenreader\"> 2085018381833347219<\/span><\/a>\n            <\/div>\n            <\/div>\n            <div class=\"ctf-corner-logo\" >\n            <svg width=\"30\" height=\"30\" viewBox=\"0 0 30 30\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M21.1161 6.27344H24.2289L17.4284 14.0459L25.4286 24.6225H19.1645L14.2583 18.2079L8.6444 24.6225H5.52976L12.8035 16.309L5.12891 6.27344H11.552L15.9868 12.1367L21.1161 6.27344ZM20.0236 22.7594H21.7484L10.6148 8.03871H8.7639L20.0236 22.7594Z\" fill=\"black\"\/>\n\t\t\t<\/svg>        <\/div>\n    <\/div>\n\n        <div class=\"ctf-tweet-content ctf-disable-lightbox\">\n        \t\t\t\t<p class=\"ctf-tweet-text\">Which vaccines have had the biggest impact on preventing deaths and keeping people healthy? <br \/>\n <br \/>\nResearchers compared 14 vaccine programmes across 117 countries, and found that HPV and measles vaccine programmes  came out on top in terms of deaths and disease prevented. The <\/p>\n\t\t\t\t\t\t\n        \n<div class=\"ctf-tweet-media\"  data-available-images=\"[{&quot;150&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO95K01XkAARnTD.jpg:thumb&quot;,&quot;674&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO95K01XkAARnTD.jpg:small&quot;,&quot;1190&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO95K01XkAARnTD.jpg&quot;,&quot;1200&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO95K01XkAARnTD.jpg:large&quot;}]\" >\n    \n                            <a href=\"https:\/\/twitter.com\/gavi\/status\/2085018381833347219\" class=\"ctf-media-link\" data-bg-image=\"https:\/\/pbs.twimg.com\/media\/HO95K01XkAARnTD.jpg\"  target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n                        <svg aria-label=\"play button\" style=\"color: rgba(255,255,255,1)\" class=\"svg-inline--fa fa-play fa-w-14 ctf_playbtn\" aria-hidden=\"true\" data-fa-processed=\"\" data-prefix=\"fa\" data-icon=\"play\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path fill=\"currentColor\" d=\"M424.4 214.7L72.4 6.6C43.8-10.3 0 6.1 0 47.9V464c0 37.5 40.7 60.1 72.4 41.3l352-208c31.4-18.5 31.5-64.1 0-82.6z\"><\/path><\/svg>                \n                                    <img decoding=\"async\" src=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/img\/placeholder.png\" alt=\"Bild f\u00fcr den Anfang des Tweets: Which vaccines have had the\"  data-ctfsizes=\"150,674,1190,1200\" data-full-image=\"https:\/\/pbs.twimg.com\/media\/HO95K01XkAARnTD.jpg\">\n                \n                <span class=\"ctf-screenreader\">Twitter Feed Bild.<\/span>                        <\/a>\n                        \n    <\/div>\n\n\t    \n        \n    <\/div>\n    \n\t\n    <div class=\"ctf-tweet-actions\" >\n            <a href=\"https:\/\/twitter.com\/intent\/tweet?in_reply_to=2085018381833347219&#038;related=gavi\" class=\"ctf-reply\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-label=\"reply\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><g><path fill=\"currentColor\" d=\"M14.046 2.242l-4.148-.01h-.002c-4.374 0-7.8 3.427-7.8 7.802 0 4.098 3.186 7.206 7.465 7.37v3.828c0 .108.044.286.12.403.142.225.384.347.632.347.138 0 .277-.038.402-.118.264-.168 6.473-4.14 8.088-5.506 1.902-1.61 3.04-3.97 3.043-6.312v-.017c-.006-4.367-3.43-7.787-7.8-7.788zm3.787 12.972c-1.134.96-4.862 3.405-6.772 4.643V16.67c0-.414-.335-.75-.75-.75h-.396c-3.66 0-6.318-2.476-6.318-5.886 0-3.534 2.768-6.302 6.3-6.302l4.147.01h.002c3.532 0 6.3 2.766 6.302 6.296-.003 1.91-.942 3.844-2.514 5.176z\"><\/path><\/g><\/svg>            <span class=\"ctf-screenreader\">Auf Twitter antworten 2085018381833347219<\/span>\n        <\/a>\n\n        <a href=\"https:\/\/twitter.com\/intent\/retweet?tweet_id=2085018381833347219&#038;related=gavi\" class=\"ctf-retweet\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"retweet\" role=\"img\"><path fill=\"currentColor\" d=\"M23.77 15.67c-.292-.293-.767-.293-1.06 0l-2.22 2.22V7.65c0-2.068-1.683-3.75-3.75-3.75h-5.85c-.414 0-.75.336-.75.75s.336.75.75.75h5.85c1.24 0 2.25 1.01 2.25 2.25v10.24l-2.22-2.22c-.293-.293-.768-.293-1.06 0s-.294.768 0 1.06l3.5 3.5c.145.147.337.22.53.22s.383-.072.53-.22l3.5-3.5c.294-.292.294-.767 0-1.06zm-10.66 3.28H7.26c-1.24 0-2.25-1.01-2.25-2.25V6.46l2.22 2.22c.148.147.34.22.532.22s.384-.073.53-.22c.293-.293.293-.768 0-1.06l-3.5-3.5c-.293-.294-.768-.294-1.06 0l-3.5 3.5c-.294.292-.294.767 0 1.06s.767.293 1.06 0l2.22-2.22V16.7c0 2.068 1.683 3.75 3.75 3.75h5.85c.414 0 .75-.336.75-.75s-.337-.75-.75-.75z\"><\/path><\/svg>            <span class=\"ctf-screenreader\">Retweet auf Twitter 2085018381833347219<\/span>\n            <span class=\"ctf-action-count ctf-retweet-count\">23<\/span>\n        <\/a>\n\n        <a href=\"https:\/\/twitter.com\/intent\/like?tweet_id=2085018381833347219&#038;related=gavi\" class=\"ctf-like\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"like\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><g><path fill=\"currentColor\" d=\"M12 21.638h-.014C9.403 21.59 1.95 14.856 1.95 8.478c0-3.064 2.525-5.754 5.403-5.754 2.29 0 3.83 1.58 4.646 2.73.814-1.148 2.354-2.73 4.645-2.73 2.88 0 5.404 2.69 5.404 5.755 0 6.376-7.454 13.11-10.037 13.157H12zM7.354 4.225c-2.08 0-3.903 1.988-3.903 4.255 0 5.74 7.034 11.596 8.55 11.658 1.518-.062 8.55-5.917 8.55-11.658 0-2.267-1.823-4.255-3.903-4.255-2.528 0-3.94 2.936-3.952 2.965-.23.562-1.156.562-1.387 0-.014-.03-1.425-2.965-3.954-2.965z\"><\/path><\/g><\/svg>            <span class=\"ctf-screenreader\">Auf Twitter liken 2085018381833347219<\/span>\n            <span class=\"ctf-action-count ctf-favorite-count\">40<\/span>\n        <\/a>\n\n                    <a href=\"https:\/\/twitter.com\/gavi\/status\/2085018381833347219\" class=\"ctf-twitterlink\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >\n                <span >Twitter<\/span>\n                <span class=\"ctf-screenreader\">2085018381833347219<\/span>\n            <\/a>\n            \n\t<\/div>\n\n\t<\/div>\n\n\n<div class=\"ctf-item ctf-author-thervacb_eu ctf-new ctf-transition ctf-with-logo ctf-retweet\" id=\"ctf_2085274438052794818\">\n\n    <div class=\"ctf-context\" >\n    <a href=\"https:\/\/twitter.com\/intent\/user?screen_name=TherVacB_EU\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-retweet-icon\"><svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"retweet\" role=\"img\"><path fill=\"currentColor\" d=\"M23.77 15.67c-.292-.293-.767-.293-1.06 0l-2.22 2.22V7.65c0-2.068-1.683-3.75-3.75-3.75h-5.85c-.414 0-.75.336-.75.75s.336.75.75.75h5.85c1.24 0 2.25 1.01 2.25 2.25v10.24l-2.22-2.22c-.293-.293-.768-.293-1.06 0s-.294.768 0 1.06l3.5 3.5c.145.147.337.22.53.22s.383-.072.53-.22l3.5-3.5c.294-.292.294-.767 0-1.06zm-10.66 3.28H7.26c-1.24 0-2.25-1.01-2.25-2.25V6.46l2.22 2.22c.148.147.34.22.532.22s.384-.073.53-.22c.293-.293.293-.768 0-1.06l-3.5-3.5c-.293-.294-.768-.294-1.06 0l-3.5 3.5c-.294.292-.294.767 0 1.06s.767.293 1.06 0l2.22-2.22V16.7c0 2.068 1.683 3.75 3.75 3.75h5.85c.414 0 .75-.336.75-.75s-.337-.75-.75-.75z\"><\/path><\/svg><span class=\"ctf-screenreader\">Retweet auf Twitter<\/span><\/a>\n    <a href=\"https:\/\/twitter.com\/thervacb_eu\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-retweet-text\">TherVacB Project Retweetet<\/a>\n<\/div>\n\n<div class=\"ctf-author-box\">\n    <div class=\"ctf-author-box-link\">\n                                    <a href=\"https:\/\/twitter.com\/liverfellow\" class=\"ctf-author-avatar\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >\n                    <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/img\/placeholder.png\" alt=\"LiverFellow avatar\" data-avatar=\"https:\/\/pbs.twimg.com\/profile_images\/1654179936972750874\/4sjFPgZj_normal.jpg\" width=\"48\" height=\"48\">;\n                <\/a>\n            \n                            <a href=\"https:\/\/twitter.com\/liverfellow\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-author-name\" >Liver Fellow Network<\/a>\n                                <a href=\"https:\/\/twitter.com\/liverfellow\" class=\"ctf-author-screenname\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >@LiverFellow<\/a>\n                    \n        \t\t                    <span class=\"ctf-screename-sep\" >&middot;<\/span>\n\t                    <div class=\"ctf-tweet-meta\" >\n              <a href=\"https:\/\/twitter.com\/liverfellow\/status\/2085098645527933308\" class=\"ctf-tweet-date\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >5 Aug. <span class=\"ctf-screenreader\"> 2085098645527933308<\/span><\/a>\n            <\/div>\n            <\/div>\n            <div class=\"ctf-corner-logo\" >\n            <svg width=\"30\" height=\"30\" viewBox=\"0 0 30 30\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M21.1161 6.27344H24.2289L17.4284 14.0459L25.4286 24.6225H19.1645L14.2583 18.2079L8.6444 24.6225H5.52976L12.8035 16.309L5.12891 6.27344H11.552L15.9868 12.1367L21.1161 6.27344ZM20.0236 22.7594H21.7484L10.6148 8.03871H8.7639L20.0236 22.7594Z\" fill=\"black\"\/>\n\t\t\t<\/svg>        <\/div>\n    <\/div>\n\n        <div class=\"ctf-tweet-content ctf-disable-lightbox\">\n        \t\t\t\t<p class=\"ctf-tweet-text\">\ud83d\udea8 #LFNQoTW | Question 4<br \/>\n<br \/>\nA 51-year-old woman comes to establish care at your clinic.<br \/>\n<br \/>\nWhich of the following statements is true about this patient?<br \/>\n<br \/>\nSelect your answer in the poll below \ud83d\udc47 <br \/>\n<br \/>\nAnswer will be posted on Friday \ud83d\uddd3\ufe0f<br \/>\n<br \/>\n#LFN #MedEd #Hepatology <\/p>\n\t\t\t\t\t\t\n        \n<div class=\"ctf-tweet-media\"  data-available-images=\"[{&quot;150&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO_CKSwX0AAbV1F.jpg:thumb&quot;,&quot;680&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO_CKSwX0AAbV1F.jpg:small&quot;,&quot;1200&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO_CKSwX0AAbV1F.jpg&quot;,&quot;1663&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/media\\\/HO_CKSwX0AAbV1F.jpg:large&quot;}]\" >\n    \n                            <a href=\"https:\/\/twitter.com\/LiverFellow\/status\/2085098645527933308\" class=\"ctf-media-link\" data-bg-image=\"https:\/\/pbs.twimg.com\/media\/HO_CKSwX0AAbV1F.jpg\"  target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n                        <svg aria-label=\"play button\" style=\"color: rgba(255,255,255,1)\" class=\"svg-inline--fa fa-play fa-w-14 ctf_playbtn\" aria-hidden=\"true\" data-fa-processed=\"\" data-prefix=\"fa\" data-icon=\"play\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path fill=\"currentColor\" d=\"M424.4 214.7L72.4 6.6C43.8-10.3 0 6.1 0 47.9V464c0 37.5 40.7 60.1 72.4 41.3l352-208c31.4-18.5 31.5-64.1 0-82.6z\"><\/path><\/svg>                \n                                    <img decoding=\"async\" src=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/img\/placeholder.png\" alt=\"Bild f\u00fcr den Anfang des Tweets: \ud83d\udea8 #LFNQoTW | Question 4\n\nA\"  data-ctfsizes=\"150,680,1200,1663\" data-full-image=\"https:\/\/pbs.twimg.com\/media\/HO_CKSwX0AAbV1F.jpg\">\n                \n                <span class=\"ctf-screenreader\">Twitter Feed Bild.<\/span>                        <\/a>\n                        \n    <\/div>\n\n\t    \n        \n    <\/div>\n    \n\t\n    <div class=\"ctf-tweet-actions\" >\n            <a href=\"https:\/\/twitter.com\/intent\/tweet?in_reply_to=2085098645527933308&#038;related=liverfellow\" class=\"ctf-reply\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-label=\"reply\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><g><path fill=\"currentColor\" d=\"M14.046 2.242l-4.148-.01h-.002c-4.374 0-7.8 3.427-7.8 7.802 0 4.098 3.186 7.206 7.465 7.37v3.828c0 .108.044.286.12.403.142.225.384.347.632.347.138 0 .277-.038.402-.118.264-.168 6.473-4.14 8.088-5.506 1.902-1.61 3.04-3.97 3.043-6.312v-.017c-.006-4.367-3.43-7.787-7.8-7.788zm3.787 12.972c-1.134.96-4.862 3.405-6.772 4.643V16.67c0-.414-.335-.75-.75-.75h-.396c-3.66 0-6.318-2.476-6.318-5.886 0-3.534 2.768-6.302 6.3-6.302l4.147.01h.002c3.532 0 6.3 2.766 6.302 6.296-.003 1.91-.942 3.844-2.514 5.176z\"><\/path><\/g><\/svg>            <span class=\"ctf-screenreader\">Auf Twitter antworten 2085098645527933308<\/span>\n        <\/a>\n\n        <a href=\"https:\/\/twitter.com\/intent\/retweet?tweet_id=2085098645527933308&#038;related=liverfellow\" class=\"ctf-retweet\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"retweet\" role=\"img\"><path fill=\"currentColor\" d=\"M23.77 15.67c-.292-.293-.767-.293-1.06 0l-2.22 2.22V7.65c0-2.068-1.683-3.75-3.75-3.75h-5.85c-.414 0-.75.336-.75.75s.336.75.75.75h5.85c1.24 0 2.25 1.01 2.25 2.25v10.24l-2.22-2.22c-.293-.293-.768-.293-1.06 0s-.294.768 0 1.06l3.5 3.5c.145.147.337.22.53.22s.383-.072.53-.22l3.5-3.5c.294-.292.294-.767 0-1.06zm-10.66 3.28H7.26c-1.24 0-2.25-1.01-2.25-2.25V6.46l2.22 2.22c.148.147.34.22.532.22s.384-.073.53-.22c.293-.293.293-.768 0-1.06l-3.5-3.5c-.293-.294-.768-.294-1.06 0l-3.5 3.5c-.294.292-.294.767 0 1.06s.767.293 1.06 0l2.22-2.22V16.7c0 2.068 1.683 3.75 3.75 3.75h5.85c.414 0 .75-.336.75-.75s-.337-.75-.75-.75z\"><\/path><\/svg>            <span class=\"ctf-screenreader\">Retweet auf Twitter 2085098645527933308<\/span>\n            <span class=\"ctf-action-count ctf-retweet-count\">5<\/span>\n        <\/a>\n\n        <a href=\"https:\/\/twitter.com\/intent\/like?tweet_id=2085098645527933308&#038;related=liverfellow\" class=\"ctf-like\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"like\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><g><path fill=\"currentColor\" d=\"M12 21.638h-.014C9.403 21.59 1.95 14.856 1.95 8.478c0-3.064 2.525-5.754 5.403-5.754 2.29 0 3.83 1.58 4.646 2.73.814-1.148 2.354-2.73 4.645-2.73 2.88 0 5.404 2.69 5.404 5.755 0 6.376-7.454 13.11-10.037 13.157H12zM7.354 4.225c-2.08 0-3.903 1.988-3.903 4.255 0 5.74 7.034 11.596 8.55 11.658 1.518-.062 8.55-5.917 8.55-11.658 0-2.267-1.823-4.255-3.903-4.255-2.528 0-3.94 2.936-3.952 2.965-.23.562-1.156.562-1.387 0-.014-.03-1.425-2.965-3.954-2.965z\"><\/path><\/g><\/svg>            <span class=\"ctf-screenreader\">Auf Twitter liken 2085098645527933308<\/span>\n            <span class=\"ctf-action-count ctf-favorite-count\">24<\/span>\n        <\/a>\n\n                    <a href=\"https:\/\/twitter.com\/liverfellow\/status\/2085098645527933308\" class=\"ctf-twitterlink\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >\n                <span >Twitter<\/span>\n                <span class=\"ctf-screenreader\">2085098645527933308<\/span>\n            <\/a>\n            \n\t<\/div>\n\n\t<\/div>\n\n\n<div class=\"ctf-item ctf-author-thervacb_eu ctf-new ctf-transition ctf-with-logo ctf-retweet\" id=\"ctf_2085274241042166201\">\n\n    <div class=\"ctf-context\" >\n    <a href=\"https:\/\/twitter.com\/intent\/user?screen_name=TherVacB_EU\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-retweet-icon\"><svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"retweet\" role=\"img\"><path fill=\"currentColor\" d=\"M23.77 15.67c-.292-.293-.767-.293-1.06 0l-2.22 2.22V7.65c0-2.068-1.683-3.75-3.75-3.75h-5.85c-.414 0-.75.336-.75.75s.336.75.75.75h5.85c1.24 0 2.25 1.01 2.25 2.25v10.24l-2.22-2.22c-.293-.293-.768-.293-1.06 0s-.294.768 0 1.06l3.5 3.5c.145.147.337.22.53.22s.383-.072.53-.22l3.5-3.5c.294-.292.294-.767 0-1.06zm-10.66 3.28H7.26c-1.24 0-2.25-1.01-2.25-2.25V6.46l2.22 2.22c.148.147.34.22.532.22s.384-.073.53-.22c.293-.293.293-.768 0-1.06l-3.5-3.5c-.293-.294-.768-.294-1.06 0l-3.5 3.5c-.294.292-.294.767 0 1.06s.767.293 1.06 0l2.22-2.22V16.7c0 2.068 1.683 3.75 3.75 3.75h5.85c.414 0 .75-.336.75-.75s-.337-.75-.75-.75z\"><\/path><\/svg><span class=\"ctf-screenreader\">Retweet auf Twitter<\/span><\/a>\n    <a href=\"https:\/\/twitter.com\/thervacb_eu\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-retweet-text\">TherVacB Project Retweetet<\/a>\n<\/div>\n\n<div class=\"ctf-author-box\">\n    <div class=\"ctf-author-box-link\">\n                                    <a href=\"https:\/\/twitter.com\/easledu\" class=\"ctf-author-avatar\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >\n                    <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/img\/placeholder.png\" alt=\"EASLedu avatar\" data-avatar=\"https:\/\/pbs.twimg.com\/profile_images\/1897934682651553792\/efFGnzRY_normal.jpg\" width=\"48\" height=\"48\">;\n                <\/a>\n            \n                            <a href=\"https:\/\/twitter.com\/easledu\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" class=\"ctf-author-name\" >EASL Education<\/a>\n                                    <span class=\"ctf-verified\" ><svg class=\"svg-inline--fa fa-check-circle fa-w-16\" aria-hidden=\"true\" aria-label=\"verified\" data-fa-processed=\"\" data-prefix=\"fa\" data-icon=\"check-circle\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path fill=\"currentColor\" d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg><\/span>\n                                <a href=\"https:\/\/twitter.com\/easledu\" class=\"ctf-author-screenname\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >@EASLedu<\/a>\n                    \n        \t\t                    <span class=\"ctf-screename-sep\" >&middot;<\/span>\n\t                    <div class=\"ctf-tweet-meta\" >\n              <a href=\"https:\/\/twitter.com\/easledu\/status\/2084576074260762822\" class=\"ctf-tweet-date\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >4 Aug. <span class=\"ctf-screenreader\"> 2084576074260762822<\/span><\/a>\n            <\/div>\n            <\/div>\n            <div class=\"ctf-corner-logo\" >\n            <svg width=\"30\" height=\"30\" viewBox=\"0 0 30 30\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M21.1161 6.27344H24.2289L17.4284 14.0459L25.4286 24.6225H19.1645L14.2583 18.2079L8.6444 24.6225H5.52976L12.8035 16.309L5.12891 6.27344H11.552L15.9868 12.1367L21.1161 6.27344ZM20.0236 22.7594H21.7484L10.6148 8.03871H8.7639L20.0236 22.7594Z\" fill=\"black\"\/>\n\t\t\t<\/svg>        <\/div>\n    <\/div>\n\n        <div class=\"ctf-tweet-content ctf-disable-lightbox\">\n        \t\t\t\t<p class=\"ctf-tweet-text\">Ready to lead your own research group? \ud83d\udd2c<br \/>\n<br \/>\nThe science may be familiar but what about managing a team, securing funding, building a research programme and planning a sustainable career?\ud83e\udee3<br \/>\n<br \/>\nThe next episode of #TalkLiverToMe explores what research independence really looks like. <\/p>\n\t\t\t\t\t\t\n        \n<div class=\"ctf-tweet-media\"  data-available-images=\"[{&quot;150&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/amplify_video_thumb\\\/2079124582653415424\\\/img\\\/Wmk-KgnGKRT_7ycZ.jpg:thumb&quot;,&quot;680&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/amplify_video_thumb\\\/2079124582653415424\\\/img\\\/Wmk-KgnGKRT_7ycZ.jpg:small&quot;,&quot;1200&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/amplify_video_thumb\\\/2079124582653415424\\\/img\\\/Wmk-KgnGKRT_7ycZ.jpg&quot;,&quot;1280&quot;:&quot;https:\\\/\\\/pbs.twimg.com\\\/amplify_video_thumb\\\/2079124582653415424\\\/img\\\/Wmk-KgnGKRT_7ycZ.jpg:large&quot;}]\" >\n    \n                            <svg aria-label=\"play button\" style=\"color: rgba(255,255,255,1)\" class=\"svg-inline--fa fa-play fa-w-14 ctf_playbtn\" aria-hidden=\"true\" data-fa-processed=\"\" data-prefix=\"fa\" data-icon=\"play\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\"><path fill=\"currentColor\" d=\"M424.4 214.7L72.4 6.6C43.8-10.3 0 6.1 0 47.9V464c0 37.5 40.7 60.1 72.4 41.3l352-208c31.4-18.5 31.5-64.1 0-82.6z\"><\/path><\/svg>                \n                \n                \n\t\t\t\t\t<video controls src=\"\" data-src=\"https:\/\/video.twimg.com\/amplify_video\/2079124582653415424\/vid\/avc1\/1280x720\/61gDaaUaBZsFg024.mp4\" type=\"video\/mp4\" poster=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/img\/placeholder.png\">\n\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/img\/placeholder.png\" alt=\"Bild f\u00fcr den Anfang des Tweets: Ready to lead your own\" \/>\n\t\t\t\t\t<\/video>\n\n                \n                \n                <span class=\"ctf-screenreader\">Twitter-Feed-Video.<\/span>                        \n    <\/div>\n\n\t    \n        \n    <\/div>\n    \n\t\n    <div class=\"ctf-tweet-actions\" >\n            <a href=\"https:\/\/twitter.com\/intent\/tweet?in_reply_to=2084576074260762822&#038;related=easledu\" class=\"ctf-reply\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-label=\"reply\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><g><path fill=\"currentColor\" d=\"M14.046 2.242l-4.148-.01h-.002c-4.374 0-7.8 3.427-7.8 7.802 0 4.098 3.186 7.206 7.465 7.37v3.828c0 .108.044.286.12.403.142.225.384.347.632.347.138 0 .277-.038.402-.118.264-.168 6.473-4.14 8.088-5.506 1.902-1.61 3.04-3.97 3.043-6.312v-.017c-.006-4.367-3.43-7.787-7.8-7.788zm3.787 12.972c-1.134.96-4.862 3.405-6.772 4.643V16.67c0-.414-.335-.75-.75-.75h-.396c-3.66 0-6.318-2.476-6.318-5.886 0-3.534 2.768-6.302 6.3-6.302l4.147.01h.002c3.532 0 6.3 2.766 6.302 6.296-.003 1.91-.942 3.844-2.514 5.176z\"><\/path><\/g><\/svg>            <span class=\"ctf-screenreader\">Auf Twitter antworten 2084576074260762822<\/span>\n        <\/a>\n\n        <a href=\"https:\/\/twitter.com\/intent\/retweet?tweet_id=2084576074260762822&#038;related=easledu\" class=\"ctf-retweet\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"retweet\" role=\"img\"><path fill=\"currentColor\" d=\"M23.77 15.67c-.292-.293-.767-.293-1.06 0l-2.22 2.22V7.65c0-2.068-1.683-3.75-3.75-3.75h-5.85c-.414 0-.75.336-.75.75s.336.75.75.75h5.85c1.24 0 2.25 1.01 2.25 2.25v10.24l-2.22-2.22c-.293-.293-.768-.293-1.06 0s-.294.768 0 1.06l3.5 3.5c.145.147.337.22.53.22s.383-.072.53-.22l3.5-3.5c.294-.292.294-.767 0-1.06zm-10.66 3.28H7.26c-1.24 0-2.25-1.01-2.25-2.25V6.46l2.22 2.22c.148.147.34.22.532.22s.384-.073.53-.22c.293-.293.293-.768 0-1.06l-3.5-3.5c-.293-.294-.768-.294-1.06 0l-3.5 3.5c-.294.292-.294.767 0 1.06s.767.293 1.06 0l2.22-2.22V16.7c0 2.068 1.683 3.75 3.75 3.75h5.85c.414 0 .75-.336.75-.75s-.337-.75-.75-.75z\"><\/path><\/svg>            <span class=\"ctf-screenreader\">Retweet auf Twitter 2084576074260762822<\/span>\n            <span class=\"ctf-action-count ctf-retweet-count\">3<\/span>\n        <\/a>\n\n        <a href=\"https:\/\/twitter.com\/intent\/like?tweet_id=2084576074260762822&#038;related=easledu\" class=\"ctf-like\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">\n            <svg class=\"svg-inline--fa fa-w-16\" viewBox=\"0 0 24 24\" aria-hidden=\"true\" aria-label=\"like\" role=\"img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><g><path fill=\"currentColor\" d=\"M12 21.638h-.014C9.403 21.59 1.95 14.856 1.95 8.478c0-3.064 2.525-5.754 5.403-5.754 2.29 0 3.83 1.58 4.646 2.73.814-1.148 2.354-2.73 4.645-2.73 2.88 0 5.404 2.69 5.404 5.755 0 6.376-7.454 13.11-10.037 13.157H12zM7.354 4.225c-2.08 0-3.903 1.988-3.903 4.255 0 5.74 7.034 11.596 8.55 11.658 1.518-.062 8.55-5.917 8.55-11.658 0-2.267-1.823-4.255-3.903-4.255-2.528 0-3.94 2.936-3.952 2.965-.23.562-1.156.562-1.387 0-.014-.03-1.425-2.965-3.954-2.965z\"><\/path><\/g><\/svg>            <span class=\"ctf-screenreader\">Auf Twitter liken 2084576074260762822<\/span>\n            <span class=\"ctf-action-count ctf-favorite-count\">6<\/span>\n        <\/a>\n\n                    <a href=\"https:\/\/twitter.com\/easledu\/status\/2084576074260762822\" class=\"ctf-twitterlink\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" >\n                <span >Twitter<\/span>\n                <span class=\"ctf-screenreader\">2084576074260762822<\/span>\n            <\/a>\n            \n\t<\/div>\n\n\t<\/div>\n\n    <\/div>\n\n        <a href=\"javascript:void(0);\" id=\"ctf-more\" class=\"ctf-more\" ><span>Load More<\/span><\/a>\n\n<span class=\"ctf-resized-image-data\" data-feedid=\"4\" data-resized=\"[{&quot;media_id&quot;:&quot;2085275144608440456&quot;,&quot;twitter_id&quot;:&quot;2085275144608440456&quot;,&quot;sizes&quot;:&quot;[800,400]&quot;},{&quot;media_id&quot;:&quot;2085274868308721706&quot;,&quot;twitter_id&quot;:&quot;2085274868308721706&quot;,&quot;sizes&quot;:&quot;[800,400]&quot;},{&quot;media_id&quot;:&quot;2085274438052794818&quot;,&quot;twitter_id&quot;:&quot;2085274438052794818&quot;,&quot;sizes&quot;:&quot;[800,400]&quot;},{&quot;media_id&quot;:&quot;2085274241042166201&quot;,&quot;twitter_id&quot;:&quot;2085274241042166201&quot;,&quot;sizes&quot;:&quot;[800,400]&quot;}]\"><\/span><script> var ctfOptions = {\"ajax_url\":\"https:\\\/\\\/www.thervacb.eu\\\/wp-admin\\\/admin-ajax.php\",\"font_method\":\"svg\",\"placeholder\":\"https:\\\/\\\/www.thervacb.eu\\\/wp-content\\\/plugins\\\/custom-twitter-feeds-pro\\\/img\\\/placeholder.png\",\"resized_url\":\"https:\\\/\\\/www.thervacb.eu\\\/wp-content\\\/uploads\\\/sb-twitter-feed-images\\\/\"}<\/script><script type=\"text\/javascript\" src=\"https:\/\/www.thervacb.eu\/wp-content\/plugins\/custom-twitter-feeds-pro\/js\/ctf-scripts.min.js?ver=2.4.1\"><\/script>\n<\/div>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neues Konzept zur Bek\u00e4mpfung der chronischen Hepatitis BNeue Hoffnung f\u00fcr Hepatitis-B-PatientenTherVacB &#8211; EIN THERAPEUTISCHER IMPFSTOFF GEGEN HEPATITIS B Europ\u00e4ische Kommission und TherVacB b\u00fcndeln ihre Kr\u00e4fte Die Rolle der viralen Hepatitis als Bedrohung der \u00f6ffentlichen Gesundheit wurde lange Zeit untersch\u00e4tzt. Erst k\u00fcrzlich haben die Vereinten Nationen in ihrer &#8222;2030 Agenda f\u00fcr nachhaltige Entwicklung&#8220; zu internationalen Ma\u00dfnahmen [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":2276,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-1969","page","type-page","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 20244 beginnt\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"keywords\" content=\"thervacb,impfstoff,h2020,hepatitis b,klinische studie\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.thervacb.eu\/de\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"de_DE\" \/>\n\t\t<meta property=\"og:site_name\" content=\"TherVacB project\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB\" \/>\n\t\t<meta property=\"og:description\" content=\"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 2024 beginnt\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.thervacb.eu\/de\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2021-02-05T10:09:03+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-10-22T10:19:09+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@TherVacB_EU\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 2024 beginnt\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb.png\" \/>\n\t\t<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t\t<meta name=\"twitter:data1\" content=\"Tanja Oster\" \/>\n\t\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesedauer\" \/>\n\t\t<meta name=\"twitter:data2\" content=\"18 Minuten\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#listItem\",\"name\":\"Startseite\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#listItem\",\"position\":2,\"name\":\"Startseite\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#organization\",\"name\":\"TherVacB\",\"description\":\"A therapeutic vaccine to cure Hepatitis B\",\"url\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.thervacb.eu\\\/wp-content\\\/uploads\\\/thervacb-260.png\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#organizationLogo\",\"width\":260,\"height\":81,\"caption\":\"TherVacB\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#organizationLogo\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#webpage\",\"url\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/\",\"name\":\"Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB\",\"description\":\"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 20244 beginnt\",\"inLanguage\":\"de-DE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.thervacb.eu\\\/wp-content\\\/uploads\\\/thervacb.png\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#mainImage\",\"width\":1200,\"height\":630,\"caption\":\"TherVacB\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#mainImage\"},\"datePublished\":\"2021-02-05T10:09:03+00:00\",\"dateModified\":\"2025-10-22T11:19:09+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/\",\"name\":\"TherVacB\",\"description\":\"A therapeutic vaccine to cure Hepatitis B\",\"inLanguage\":\"de-DE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.thervacb.eu\\\/de\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB","description":"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 20244 beginnt","canonical_url":"https:\/\/www.thervacb.eu\/de\/","robots":"max-image-preview:large","keywords":"thervacb,impfstoff,h2020,hepatitis b,klinische studie","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.thervacb.eu\/de\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.thervacb.eu\/de\/#listItem","position":1,"name":"Home","item":"https:\/\/www.thervacb.eu\/de\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.thervacb.eu\/de\/#listItem","name":"Startseite"}},{"@type":"ListItem","@id":"https:\/\/www.thervacb.eu\/de\/#listItem","position":2,"name":"Startseite","previousItem":{"@type":"ListItem","@id":"https:\/\/www.thervacb.eu\/de\/#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/www.thervacb.eu\/de\/#organization","name":"TherVacB","description":"A therapeutic vaccine to cure Hepatitis B","url":"https:\/\/www.thervacb.eu\/de\/","logo":{"@type":"ImageObject","url":"https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb-260.png","@id":"https:\/\/www.thervacb.eu\/de\/#organizationLogo","width":260,"height":81,"caption":"TherVacB"},"image":{"@id":"https:\/\/www.thervacb.eu\/de\/#organizationLogo"}},{"@type":"WebPage","@id":"https:\/\/www.thervacb.eu\/de\/#webpage","url":"https:\/\/www.thervacb.eu\/de\/","name":"Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB","description":"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 20244 beginnt","inLanguage":"de-DE","isPartOf":{"@id":"https:\/\/www.thervacb.eu\/de\/#website"},"breadcrumb":{"@id":"https:\/\/www.thervacb.eu\/de\/#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb.png","@id":"https:\/\/www.thervacb.eu\/de\/#mainImage","width":1200,"height":630,"caption":"TherVacB"},"primaryImageOfPage":{"@id":"https:\/\/www.thervacb.eu\/de\/#mainImage"},"datePublished":"2021-02-05T10:09:03+00:00","dateModified":"2025-10-22T11:19:09+01:00"},{"@type":"WebSite","@id":"https:\/\/www.thervacb.eu\/de\/#website","url":"https:\/\/www.thervacb.eu\/de\/","name":"TherVacB","description":"A therapeutic vaccine to cure Hepatitis B","inLanguage":"de-DE","publisher":{"@id":"https:\/\/www.thervacb.eu\/de\/#organization"}}]},"og:locale":"de_DE","og:site_name":"TherVacB project","og:type":"article","og:title":"Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB","og:description":"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 2024 beginnt","og:url":"https:\/\/www.thervacb.eu\/de\/","og:image":"https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb.png","og:image:secure_url":"https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb.png","og:image:width":"1200","og:image:height":"630","article:published_time":"2021-02-05T10:09:03+00:00","article:modified_time":"2025-10-22T10:19:09+00:00","twitter:card":"summary_large_image","twitter:site":"@TherVacB_EU","twitter:title":"Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB","twitter:description":"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 2024 beginnt","twitter:image":"https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb.png","twitter:label1":"Verfasst von","twitter:data1":"Tanja Oster","twitter:label2":"Gesch\u00e4tzte Lesedauer","twitter:data2":"18 Minuten"},"aioseo_meta_data":{"post_id":"1969","title":"Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB","description":"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 20244 beginnt","keywords":[{"label":"TherVacB","value":"TherVacB"},{"label":"Impfstoff","value":"Impfstoff"},{"label":"H2020","value":"H2020"},{"label":"Hepatitis B","value":"Hepatitis B"},{"label":"klinische Studie","value":"klinische Studie"}],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":"Ein therapeutischer Impfstoff zur Heilung von Hepatitis B - TherVacB","og_description":"Forschungsprojekt zur Heilung von Hepatitis-B-Patienten im Rahmen des europ\u00e4ischen Programms Horizont 2020 unter Verwendung eines neu entwickelten Impfstoffs in einer klinischen Studie, die im Jahr 2024 beginnt","og_object_type":"default","og_image_type":"featured","og_image_url":"https:\/\/www.thervacb.eu\/wp-content\/uploads\/thervacb.png","og_image_width":"1200","og_image_height":"630","og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"summary_large_image","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[],"defaultGraph":"","defaultPostTypeGraph":""},"schema_type":"none","schema_type_options":"{\"article\":{\"articleType\":\"BlogPosting\"},\"course\":{\"name\":\"\",\"description\":\"\",\"provider\":\"\"},\"faq\":{\"pages\":[]},\"product\":{\"reviews\":[]},\"recipe\":{\"ingredients\":[],\"instructions\":[],\"keywords\":[]},\"software\":{\"reviews\":[],\"operatingSystems\":[]},\"webPage\":{\"webPageType\":\"WebPage\"},\"book\":[],\"event\":[],\"jobPosting\":[],\"music\":[],\"person\":[],\"restaurant\":[],\"service\":[],\"video\":[]}","pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2021-02-05 10:09:04","updated":"2025-10-22 10:21:53","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"_links":{"self":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/1969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/comments?post=1969"}],"version-history":[{"count":13,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/1969\/revisions"}],"predecessor-version":[{"id":13314,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/1969\/revisions\/13314"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/media\/2276"}],"wp:attachment":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/media?parent=1969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}